Cybersecurity moment for Biological Security is here.
ENCRYPTION FOR BIOLOGICAL IP
Engineered cells are the living factories powering modern life. Each cell line is decades of R&D compressed into a vial, and one vial can seed a production line worldwide. Since locked doors and contracts are the only protections available, organizations don't make the licensing deals that grow the business.
GeneLock™ puts the lock inside the DNA itself, so you can unlock revenue.
Invented at Georgia Tech
Patent Pending
Independently Tested
Your most valuable IP cannot be fully monetized.
We have found novel ways to harness the power of cells to make the things we need, such as ingredients for medicines, cosmetics, household products, fuels, and food, in a way that is faster, better, and cheaper than traditional methods.
These engineered cells power a $1.5T slice of the global economy today, and each cell line is a genetic program worth hundreds of millions of dollars and years of R&D.
Cell lines are protected with locked freezers and legal agreements. Neither stops theft during storage or when the cells are shipped to a contract manufacturer, a licensing partner, or an overseas site.
That’s because, unlike software, the prevailing wisdom is that biology can't be encrypted. Until now.
How GeneLock™ Works
GeneLock™ scrambles the valuable gene at the DNA level. Without the right chemical passcode, the cell doesn’t produce the output.
Invented at Georgia Tech. GeneLock™ was invented by Prof. Corey Wilson with funding from the NSF. Published in Science Advances.
Independently tested. In a biohackathon, a team with full knowledge of the system and full set of chemical inputs still couldn't break it. Unlike software, each attempt takes days of lab work.
Three industries.
One vulnerability.
Industrial Biomanufacturers
Enzyme, reagent, and specialty-chemical producers.
Pharmaceuticals
Companies developing cancer therapies, insulin, and other medicines and biologics.
Federal Labs &
National Security
Defense agencies and research programs working with engineered organisms and pathogens.
Our Team
Built by a Georgia Tech Professor and a seasoned startup operator, GeneLock is a revolutionary technology that secures the future of the biomanufacturing industry.
Dr. Corey Wilson
Love Family Endowed Professor, Georgia Tech School of Chemical & Biomolecular Engineering. Inventor of Transcriptional Programming, the platform behind GeneLock™. $20M+ in research funding raised; eight years on faculty at Yale before Georgia Tech.
Founder & Inventor
Dr. Nammy Vedire
PhD in Electrical Engineering, Yale. A decade in deep-tech commercialization and enterprise go-to-market. Heading up Portfolio Success at Alloy and most recently served as COO of Metaimpact (Series A startup).
Chief Executive Officer“By combining the huge variation possible in DNA with many small chemical molecules and testing the system in this way, the work is both innovative and of vital interest to the security of biotechnologies at many levels.”
Clifford Weil, Program Director, NSF Directorate for Biological Sciences
Let’s Talk
We're in active conversations with biomanufacturers and investors. If what we are building is interesting, we'd like to hear from you.